TY - CHAP
T1 - Lipid-Based Formulations for siRNA Delivery
AU - Foged, Camilla
AU - Vader, Pieter
AU - Schiffelers, Raymond M.
PY - 2009/12/11
Y1 - 2009/12/11
KW - Active targeting strategies
KW - Cationic lipid-based delivery systems for nucleic acid-based drugs
KW - Immune activation- superior abilities in transfecting cells
KW - Lipid-based delivery systems for siRNA
KW - Lipid-based formulations for siRNA delivery
KW - Multiple in vivo experiments- promising therapeutic efficacy of siRNA
KW - Neutral and anionic lipid-based drug delivery systems
KW - RNA interference (RNAi)- conserved process for post-transcriptional silencing
UR - https://www.scopus.com/pages/publications/84876730581
U2 - 10.1002/9780470688397.ch15
DO - 10.1002/9780470688397.ch15
M3 - Chapter
AN - SCOPUS:84876730581
SN - 9780470723388
SP - 291
EP - 304
BT - Delivery Technologies for Biopharmaceuticals
PB - John Wiley & Sons Inc.
ER -